Literature DB >> 15234221

The role of phospholipase C and phosphatidylinositol 3-kinase in vascular smooth muscle cell migration and proliferation.

Bo Liu1, Hiroyuki Itoh, Otway Louie, Kenji Kubota, K Craig Kent.   

Abstract

BACKGROUND: Vascular smooth muscle cell (SMC) proliferation and migration both contribute to the formation of intimal hyperplasia. Phospholipase C (PLC) and phosphatidylinositol 3-kinase (PI3-K) are ubiquitous signaling proteins that mediate multiple cellular events. In this study, we investigate the role of PLC and PI3-K in platelet-derived growth factor (PDGF) and extracellular matrix protein (ECM) induced SMC proliferation and migration.
MATERIAL AND METHODS: Proliferation of human saphenous vein SMC was assessed by (3)H-thymidine incorporation. SMC migration was evaluated using a microchemotaxis chamber. U-73122 was used as a general inhibitor for PLC, and D609 and ET-18-OCH3, respectively, were used to block the isotypes of PLC, phosphatidylcholine- (PC-), and phosphatidylinositol- (PI-) specific PLC. PI3-K activity was inhibited using two selective inhibitors, LY-294002 and wortmannin.
RESULTS: PDGF and Type 1 collagen (CN-I) stimulated SMC proliferation, whereas PDGF and four distinct extracellular matrix proteins CN-I, Type 4 collagen (CN-IV), fibronectin (FN), and laminin (LN) stimulated SMC migration. Both isotypes of PLC as well as PI3-K were necessary for PDGF- and CN-I-induced proliferation. Signaling for migration, however, was more specific. Of the various signaling proteins studied, only PI-PLC was necessary for PDGF-induced SMC migration. Conversely, PI3-K was the only signaling protein necessary for SMC migration in response to ECM proteins.
CONCLUSION: The signaling pathways necessary for PDGF- and CN-I-induced SMC proliferation involve both isotypes of PLC as well as PI3-K. The signaling pathways used by growth factors and ECM to stimulate SMC migration are more selective. Understanding the intracellular signaling pathways required for SMC proliferation and migration may allow the development of tools to selectively block intimal hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15234221     DOI: 10.1016/j.jss.2003.12.015

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.

Authors:  Jane E Lauckner; Bertil Hille; Ken Mackie
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

2.  Phosphorylation of the cyclic AMP response element binding protein mediates transforming growth factor beta-induced downregulation of cyclin A in vascular smooth muscle cells.

Authors:  Kentaro Kamiya; Kenji Sakakibara; Evan J Ryer; Raymond P Hom; Edward B Leof; K Craig Kent; Bo Liu
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

3.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

Review 4.  Role of smooth muscle cells in coronary artery bypass grafting failure.

Authors:  Kerry Wadey; Joshua Lopes; Michelle Bendeck; Sarah George
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

5.  Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors.

Authors:  Jian Shan; Thomas B Nguyen; Hana Totary-Jain; Hayes Dansky; Steven O Marx; Andrew R Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-19       Impact factor: 11.205

6.  Markers of Basement Membrane Remodeling Are Associated With Higher Mortality in Patients With Known Atherosclerosis.

Authors:  Signe Holm Nielsen; Christoffer Tengryd; Andreas Edsfeldt; Susanne Brix; Federica Genovese; Eva Bengtsson; Morten Karsdal; Diana J Leeming; Jan Nilsson; Isabel Goncalves
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.